Catherine Moukheibir
Former Chief Executive Officer, MedDay Pharmaceuticals

Catherine Moukheibir joined our board of directors in April 2019. Ms. Moukheibir most recently served as chief executive officer, as well as chairman of the board of directors, of MedDay Pharmaceuticals. Prior to that, Ms. Moukheibir served as the senior advisor for finance and a member of the executive board of directors at Innate Pharma SA from March 2011 to December 2016 and as the chief financial officer for Movetis N.V. from 2008 to 2010, when it was acquired. Ms. Moukheibir previously served as the director of capital markets for Zeltia Group S.A. from 2001 to 2007.  Ms. Moukheibir also serves on the board of directors of Asceneuron SA, Biotalys NV, DNA Script, Noema Pharma, Orphazyme A/S and CMR Surgical Ltd.  She also held past directorships on the boards of directors of Ablynx NV, Cerenis Therapeutics SA, Creabilis S.A., GenKyoTex S.A., Kymab Group Limited, and Zealand Pharma A.S. Ms. Moukheibir received a M.A. in economics and an M.B.A. from Yale University.

Copyright © 2022, Ironwood Pharmaceuticals, Inc. All Rights Reserved

LINZESS®, CONSTELLA®, IRONWOOD® and their associated logos are trademarks of Ironwood Pharmaceuticals, Inc. Any other trademarks referred to herein are the property of their respective owners. All rights reserved.